Literature DB >> 7324896

Ossicular damage in chronic middle ear inflammation.

J Sade, E Berco, D Buyanover, M Brown.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7324896     DOI： 10.3109/00016488109133263

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN： 0001-6489            Impact factor:   1.494


× No keyword cloud information.
  7 in total

1.  Ossicular chain status in chronic suppurative otitis media in adults.

Authors:  Saurabh Varshney; Ashutosh Nangia; S S Bist; R K Singh; N Gupta; S Bhagat
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-01-11

2.  Pre-operative Indicators of Ossicular Necrosis in Tubotympanic CSOM.

Authors:  Celina Lovely Jayakumar; Leeberk R Inbaraj; George J O Pinto
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2016-05-09

Review 3.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

4.  Middle ear cleft in chronic otitis media: a clinicohistopathological study.

Authors:  Karan Sharma; Mridu Manjari; Neha Salaria
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-12-07

5.  Applicability of autologous incus: the influence of age and localization of cholesteatoma.

Authors:  Milan Stankovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-04-06       Impact factor: 2.503

6.  Decreased expression of autophagy markers in culture-positive patients with chronic otitis media.

Authors:  Junyang Jung; Dong Choon Park; Young Il Kim; Eun Hye Lee; Myung Jin Park; Sang Hoon Kim; Seung Geun Yeo
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

7.  Decreased Aquaporin 4 and 6 mRNAs in Patients With Chronic Otitis Media With Otorrhea.

Authors:  Ji Hoon Kim; Sung Su Kim; Young Il Kim; Su Young Jung; Sang Hoon Kim; Seung Geun Yeo
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-12-07       Impact factor: 3.372
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.